Skip to main content
Erschienen in: Medical Oncology 2/2013

01.06.2013 | Review Article

Integrating complementary medicine in supportive cancer care models across four continents

verfasst von: Eran Ben-Arye, Elad Schiff, Catherine Zollman, Peter Heusser, Pablo Mountford, Moshe Frenkel, Gil Bar-Sela, Ofer Lavie

Erschienen in: Medical Oncology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

The need to integrate complementary medicine (CM) consultation in supportive care of patients with cancer is acknowledged by oncologists owing to the ongoing research on CM efficacy and awareness of its potential risks. In this article, we aim to provide oncologists with models for CM integration within supportive care. Descriptive analysis of key elements which facilitate CM integration is presented by physicians leading six integrative cancer care programs across four continents. Perspectives of integration are supplemented by a literature review, quantitative data on the clinical activity in each center, and qualitative narrative-based citations of seven oncology patients and healthcare providers. It is recommended that CM consultation be provided by physicians with extensive CM training. The following key elements were identified as essential for integrative program design within oncological supportive care: (1) Location of the integrative physician (IP) room within the oncology department area, (2) Required oncologist referral to CM consultation, (3) Allocated time to IP-oncologist communication, (4) Research-based integrative practice, (5) Inclusion of paid professional CM practitioners, (6) Institutional cost covered service. Integration of CM consultation within oncological supportive care needs to take in account six key elements that ensure high-quality evidence-based concomitant integrative practice.
Literatur
1.
Zurück zum Zitat Burstein HJ. Discussing complementary therapies with cancer patients: what should we be talking about? J Clin Oncol. 2000;18:2501–4.PubMed Burstein HJ. Discussing complementary therapies with cancer patients: what should we be talking about? J Clin Oncol. 2000;18:2501–4.PubMed
2.
Zurück zum Zitat White F. Annual report on complementary and alternative medicine–Fiscal year 2009. Office of cancer complementary and alternative medicine, National Cancer Institute, 2009. White F. Annual report on complementary and alternative medicine–Fiscal year 2009. Office of cancer complementary and alternative medicine, National Cancer Institute, 2009.
3.
Zurück zum Zitat Geffen JR. Integrative oncology for the whole person: a multidimensional approach to cancer care. Integr Cancer Ther. 2010;9(1):105–21.PubMedCrossRef Geffen JR. Integrative oncology for the whole person: a multidimensional approach to cancer care. Integr Cancer Ther. 2010;9(1):105–21.PubMedCrossRef
4.
Zurück zum Zitat Frenkel M, Cohen L, Peterson N, et al. Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther. 2010;9(3):276–83.PubMedCrossRef Frenkel M, Cohen L, Peterson N, et al. Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther. 2010;9(3):276–83.PubMedCrossRef
5.
Zurück zum Zitat Deng G. Integrative Cancer Care in a US Academic Cancer Centre: The Memorial Sloan-Kettering Experience. Curr Oncol. 2008;Suppl 2(s108):es68–71. Deng G. Integrative Cancer Care in a US Academic Cancer Centre: The Memorial Sloan-Kettering Experience. Curr Oncol. 2008;Suppl 2(s108):es68–71.
6.
Zurück zum Zitat Deng GE, Frenkel M, Cohen L, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol. 2009;7(3):85–120.PubMed Deng GE, Frenkel M, Cohen L, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol. 2009;7(3):85–120.PubMed
7.
Zurück zum Zitat Ben-Arye E, Schiff E, Steiner M, Silbermann M. Wheatgrass in Afifi’s garden: sprouting integrative oncology collaborations in the Middle East. J Clin Oncol. 2011;29(7):944–6.PubMedCrossRef Ben-Arye E, Schiff E, Steiner M, Silbermann M. Wheatgrass in Afifi’s garden: sprouting integrative oncology collaborations in the Middle East. J Clin Oncol. 2011;29(7):944–6.PubMedCrossRef
8.
Zurück zum Zitat Koithan M, Bell IR, Caspi O, et al. Patients’ experiences and perceptions of a consultative model integrative medicine clinic: a qualitative study. Integr Cancer Ther. 2007;6(2):174–84.PubMedCrossRef Koithan M, Bell IR, Caspi O, et al. Patients’ experiences and perceptions of a consultative model integrative medicine clinic: a qualitative study. Integr Cancer Ther. 2007;6(2):174–84.PubMedCrossRef
9.
Zurück zum Zitat Harrington JE, Baker BS, Hoffman CJ. Effect of an integrated support programme on the concerns and wellbeing of women with breast cancer: a national service evaluation. Complement Ther Clin Pract. 2012;18(1):10–5.PubMedCrossRef Harrington JE, Baker BS, Hoffman CJ. Effect of an integrated support programme on the concerns and wellbeing of women with breast cancer: a national service evaluation. Complement Ther Clin Pract. 2012;18(1):10–5.PubMedCrossRef
10.
Zurück zum Zitat Kligler B, Homel P, Harrison LB, et al. Impact of the Urban Zen initiative on patients’ experience of admission to an inpatient oncology floor: a mixed-methods analysis. J Altern Complement Med. 2011;17(8):729–34.PubMedCrossRef Kligler B, Homel P, Harrison LB, et al. Impact of the Urban Zen initiative on patients’ experience of admission to an inpatient oncology floor: a mixed-methods analysis. J Altern Complement Med. 2011;17(8):729–34.PubMedCrossRef
11.
Zurück zum Zitat Ben-Arye E, Schiff E, Steiner M, et al. Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care. Int J Gynecol Cancer. 2011;22(1):146–53.CrossRef Ben-Arye E, Schiff E, Steiner M, et al. Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care. Int J Gynecol Cancer. 2011;22(1):146–53.CrossRef
12.
Zurück zum Zitat Kligler B, Homel P, Harrison LB, et al. Cost savings in inpatient oncology through an integrative medicine approach. Am J Manag Care. 2011;17(12):779–84.PubMed Kligler B, Homel P, Harrison LB, et al. Cost savings in inpatient oncology through an integrative medicine approach. Am J Manag Care. 2011;17(12):779–84.PubMed
13.
Zurück zum Zitat Ben-Arye E, Schiff E, Golan O. Ethical issues in integrative oncology. Hematol Oncol Clin North Am. 2008;22(4):737–53.PubMedCrossRef Ben-Arye E, Schiff E, Golan O. Ethical issues in integrative oncology. Hematol Oncol Clin North Am. 2008;22(4):737–53.PubMedCrossRef
14.
Zurück zum Zitat Coulter ID, Ellison MA. Hilton L, et al. Hospital-based integrative medicine. Hospital-based integrative medicine: a case study of the barriers and factors facilitating the creation of a center. Santa Monica, CA: RAND Corporation, 2007. http://www.rand.org/pubs/monographs/MG591. Coulter ID, Ellison MA. Hilton L, et al. Hospital-based integrative medicine. Hospital-based integrative medicine: a case study of the barriers and factors facilitating the creation of a center. Santa Monica, CA: RAND Corporation, 2007. http://​www.​rand.​org/​pubs/​monographs/​MG591.
15.
16.
Zurück zum Zitat Smithson J, Britten N, Paterson C, et al. The experience of using complementary therapies after a diagnosis of cancer: a qualitative synthesis. Health (London). 2012;16(1):19–39.CrossRef Smithson J, Britten N, Paterson C, et al. The experience of using complementary therapies after a diagnosis of cancer: a qualitative synthesis. Health (London). 2012;16(1):19–39.CrossRef
17.
Zurück zum Zitat Frenkel M, Cohen L. Incorporating complementary and integrative medicine in a comprehensive cancer center. Hematol Oncol Clin North Am. 2008;22(4):727–36.PubMedCrossRef Frenkel M, Cohen L. Incorporating complementary and integrative medicine in a comprehensive cancer center. Hematol Oncol Clin North Am. 2008;22(4):727–36.PubMedCrossRef
18.
Zurück zum Zitat Caspi O, Bell IR, Rychener D, et al. The tower of babel: communication and medicine: an essay on medical education and complementary-alternative medicine. Arch Intern Med. 2000;160(21):3193–5.PubMedCrossRef Caspi O, Bell IR, Rychener D, et al. The tower of babel: communication and medicine: an essay on medical education and complementary-alternative medicine. Arch Intern Med. 2000;160(21):3193–5.PubMedCrossRef
19.
Zurück zum Zitat Schiff E, Frenkel M, Shilo M, et al. Bridging the physician and CAM practitioner communication gap: suggested framework for communication between physicians and CAM practitioners based on a cross professional survey from Israel. Patient Educ Couns. 2011;85(2):188–93.PubMedCrossRef Schiff E, Frenkel M, Shilo M, et al. Bridging the physician and CAM practitioner communication gap: suggested framework for communication between physicians and CAM practitioners based on a cross professional survey from Israel. Patient Educ Couns. 2011;85(2):188–93.PubMedCrossRef
20.
Zurück zum Zitat Schiff E, Ben-Arye E, Attias S, et al. Perceiving integration of a complementary medicine service within a general surgery department through documentation of consultations: a thematic analysis. Patient Educ Couns 2012; 2012 Mar 16. [Epub ahead of print]. Schiff E, Ben-Arye E, Attias S, et al. Perceiving integration of a complementary medicine service within a general surgery department through documentation of consultations: a thematic analysis. Patient Educ Couns 2012; 2012 Mar 16. [Epub ahead of print].
21.
Zurück zum Zitat Bar-Sela G, Goldberg H, Beck D, et al. Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a viscum album extract. Anticancer Res. 2006;26(1B):709–13.PubMed Bar-Sela G, Goldberg H, Beck D, et al. Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a viscum album extract. Anticancer Res. 2006;26(1B):709–13.PubMed
22.
Zurück zum Zitat Xu H, Chen K. Integrative medicine: the experience from China. J Altern Complement Med. 2008;14(1):3–7.PubMedCrossRef Xu H, Chen K. Integrative medicine: the experience from China. J Altern Complement Med. 2008;14(1):3–7.PubMedCrossRef
23.
Zurück zum Zitat Sharf BF, Geist Martin P, Cosgriff-Hernández KK, et al. Trailblazing healthcare: institutionalizing and integrating complementary medicine. Patient Educ Couns 2012; 2012 Apr 1. [Epub ahead of print]. Sharf BF, Geist Martin P, Cosgriff-Hernández KK, et al. Trailblazing healthcare: institutionalizing and integrating complementary medicine. Patient Educ Couns 2012; 2012 Apr 1. [Epub ahead of print].
24.
Zurück zum Zitat Lawenda BD, Friedenthal SA, Sagar SM, et al. Systems modeling in integrative oncology. Integr Cancer Ther. 2011;11(1):5–17.PubMedCrossRef Lawenda BD, Friedenthal SA, Sagar SM, et al. Systems modeling in integrative oncology. Integr Cancer Ther. 2011;11(1):5–17.PubMedCrossRef
25.
Zurück zum Zitat Beatty L, Koczwara B, Knott V, et al. Why people choose to not use complementary therapies during cancer treatment: a focus group study. Eur J Cancer Care (Engl). 2012;21(1):98–106.CrossRef Beatty L, Koczwara B, Knott V, et al. Why people choose to not use complementary therapies during cancer treatment: a focus group study. Eur J Cancer Care (Engl). 2012;21(1):98–106.CrossRef
26.
Zurück zum Zitat Ben-Arye E, Steiner M, Karkabi K, et al. Barriers to integration of traditional and complementary medicine in supportive cancer care of Arab patients in northern Israel. Evid Based Complement Alternat Med. 2012;401867:2012. Ben-Arye E, Steiner M, Karkabi K, et al. Barriers to integration of traditional and complementary medicine in supportive cancer care of Arab patients in northern Israel. Evid Based Complement Alternat Med. 2012;401867:2012.
27.
Zurück zum Zitat Bar-Sela G, Wollner M, Hammer L, et al. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study. Eur J Cancer. 2012. Bar-Sela G, Wollner M, Hammer L, et al. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study. Eur J Cancer. 2012.
28.
Zurück zum Zitat Büssing A, Hedtstück A, Khalsa SB, et al. Development of specific aspects of spirituality during a 6-month intensive yoga practice. Evid Based Complement Alternat Med. 2012;2012:981523.PubMed Büssing A, Hedtstück A, Khalsa SB, et al. Development of specific aspects of spirituality during a 6-month intensive yoga practice. Evid Based Complement Alternat Med. 2012;2012:981523.PubMed
Metadaten
Titel
Integrating complementary medicine in supportive cancer care models across four continents
verfasst von
Eran Ben-Arye
Elad Schiff
Catherine Zollman
Peter Heusser
Pablo Mountford
Moshe Frenkel
Gil Bar-Sela
Ofer Lavie
Publikationsdatum
01.06.2013
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 2/2013
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-013-0511-1

Weitere Artikel der Ausgabe 2/2013

Medical Oncology 2/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.